novartis glp-1 use tripled among non-diabetics, reaching $5.8B in 2022 GLP-1 Medications Are Revolutionizing Healthcare

Remember, it's a favorite in the glam world for a reason

However, there is still a huge gap in our understanding of how our food influences the gut microbiome and the impact of the gut microbiota on general host health

The Heaven Magic Glow Combo works inside + outside to support brighter, healthier-looking skin

Millions face uncertain wait for weight-loss pills on NHS Millions of patients face an uncertain wait for the new weight-loss pill after private sales began before NHS assessment

FDA Drug Safety Communication: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes